Synthesis, characterisation and evaluation of a novel copper-64 complex with selective uptake in EMT-6 cells under hypoxic conditions (original) (raw)

Cyclam-Based Chelators Bearing Phosphonated Pyridine Pendants for ⁶⁴Cu-PET Imaging: Synthesis, Physicochemical Studies, Radiolabeling, and Bioimaging

Loïc Charbonnière

Inorganic Chemistry, 2021

View PDFchevron_right

New Bifunctional Chelator p-SCN-PhPr-NE3TA for Copper-64: Synthesis, Peptidomimetic Conjugation, Radiolabeling, and Evaluation for PET Imaging

Dexing Zeng

Inorganic chemistry, 2016

View PDFchevron_right

Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro

Jamal Zweit

European Journal of Nuclear Medicine and Molecular Imaging, 1998

View PDFchevron_right

Copper Chelation Chemistry and its Role in Copper Radiopharmaceuticals

Current Pharmaceutical Design

Bentham Science Publishers

View PDFchevron_right

Molecular imaging with copper-64

Suzanne Smith

Journal of Inorganic Biochemistry, 2004

View PDFchevron_right

Copper-64-labeled antibodies for PET imaging

Sally Schwarz

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992

View PDFchevron_right

Cyclam te1pa for⁶⁴Cu PET imaging. Bioconjugation to antibody, radiolabeling and preclinical application in xenografted colorectal cancer

Jean-François Gestin

RSC Advances, 2017

View PDFchevron_right

Novel synthetic ligands for targeted PET imaging and radiotherapy of copper

Sankar Bhuniya

Bioorganic & Medicinal Chemistry Letters, 2007

View PDFchevron_right

Monoclonal antibodies for copper-64 PET dosimetry and radioimmunotherapy

Carolyn Henry

Cancer Biology & Therapy, 2011

View PDFchevron_right

Targeting Copper in Cancer Imaging and Therapy: A New Theragnostic Agent

Gabriela Capriotti

Journal of Clinical Medicine

View PDFchevron_right

Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticals

Donald Yapp

Nuclear Medicine and Biology, 2008

View PDFchevron_right

Radiolabeling of HTE1PA: A new monopicolinate cyclam derivative for Cu-64 phenotypic imaging. In vitro and in vivo stability studies in mice

Cyrille Alliot

Nuclear Medicine and Biology, 2014

View PDFchevron_right

Comparison of Four Bifunctional Chelates for Radiolabeling Monoclonal Antibodies with Copper Radioisotopes: Biodistribution and Metabolism

Buck Rogers

Bioconjugate Chemistry, 1996

View PDFchevron_right

Copper bis(diphosphine) complexes: radiopharmaceuticals for the detection of multi-drug resistance in tumours by PET

Paul Carnochan

European Journal of Nuclear Medicine and Molecular Imaging, 2000

View PDFchevron_right

Preparation, quality control and biodistribution studies of ( 61 Cu)-oxinate for PET tumor imaging

Hassan Yousefnia

Nukleonika, 2009

View PDFchevron_right

Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes

Ulrike Bauder-wüst

Journal of Nuclear Medicine, 2019

View PDFchevron_right

Imaging cancer using PET — the effect of the bifunctional chelator on the biodistribution of a 64Cu-labeled antibody

Frederic Fahey, Erin Snay

Nuclear Medicine and Biology, 2011

View PDFchevron_right

In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62

C. Meares

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991

View PDFchevron_right

A Versatile Bifunctional Chelate for Radiolabeling Humanized Anti-CEA Antibody with In-111 and Cu-64 at Either Thiol or Amino Groups: PET Imaging Of CEA-Positive Tumors with Whole Antibodies

Paul Yazaki

Bioconjugate Chemistry, 2008

View PDFchevron_right

Comparison of bifunctional chelates for 64Cu antibody imaging

Donald Yapp

European Journal of Nuclear Medicine and Molecular Imaging, 2010

View PDFchevron_right

Development and Evaluation of Copper-67 and Samarium-153 Labeled Conjugates for Tumor Radioimmunotherapy

Ronnie Mease

Pharmaceutical Biology, 1995

View PDFchevron_right

In vitro kinetic studies on the mechanism of oxygen-dependent cellular uptake of copper radiopharmaceuticals

Jason Holland

View PDFchevron_right

Copper-67 radioimmunotheranostics for simultaneous immunotherapy and immuno-SPECT

Guiyang Hao

Scientific Reports

View PDFchevron_right

Cyclam-Based Chelators Bearing Phosphonated Pyridine Pendants for 64Cu-PET Imaging : Synthesis, Physico-Chemical Studies, Radiolabeling and Bioimaging

Loïc Charbonnière

2020

View PDFchevron_right

The emerging role of copper-64 radiopharmaceuticals as cancer theranostics

Adriano Duatti

Drug Discovery Today, 2018

View PDFchevron_right

Synthesis and Preclinical Studies of [61 Cu]-N-(2-Hydroxyacetophenone) Glycinate As a Possible PET Radiopharmaceutical

hassan zandi

Sci Pharm, 2008

View PDFchevron_right

Antibody and Nanobody Radiolabeling with Copper-64: Solid vs. Liquid Target Approach

Diana Cocioaba

Molecules

View PDFchevron_right

Synthesis, characterisation and evaluation of a novel copper-64 complex with selective uptake in EMT-6 cells under hypoxic conditions (original) (raw)

Related papers